| Literature DB >> 27339469 |
Alfredo Tartarone1, Elisabetta Rossi2, Rosa Lerose3, Giuseppina Mambella4, Giuseppe Calderone4, Rita Zamarchi5, Michele Aieta4.
Abstract
Recent experiences indicate that, as already reported for other types of cancer, circulating tumor cells (CTCs) may play a role also in non small cell lung cancer (NSCLC) for diagnosis, therapy monitoring and prognostic purposes. CTCs evaluation could be particularly relevant in this clinical setting not only for the objective difficulty in obtaining tumor tissue, but also because of the lack of reliable tumor markers. In the current review, we will focus on the possible applications of CTCs in NSCLC patients.Entities:
Keywords: Anaplastic lymphoma kinase fusion gene; Circulating tumor cells; Epidermal growth factor receptor; Liquid biopsy; Non small cell lung cancer
Mesh：
Substances：
Year: 2016 PMID： 27339469 DOI： 10.1016/j.lungcan.2016.05.027
Source DB: PubMed Journal: Lung Cancer ISSN： 0169-5002 Impact factor: 5.705